RevaleneLabs Launch in Malaysia and Singapore

Neoasia proudly launches RevaleneLabs in Singapore and Malaysia, introducing a new innovative pathway to combat hyperpigmentation with its patented Dendrix® technology. From Park Hyatt Kuala Lumpur on 17 November to The Singapore Edition Hotel on 18 November, the doctor-exclusive launch events featured insightful scientific sharing by Prof. Philippe Humbert and a brand vision presentation by Mr. Thierry Leveille-Nizerolle, bringing dermatologists and aesthetic doctors together for a comprehensive learn-and-dine session.

Both launch events showcase the full Melanclair range, emphasising its science-driven formulation and strong clinical relevance. RevaleneLabs is developed in France and backed by dermatological expertise. It offers a modern, science-led approach to pigmentation management. With strong interest from doctors across both markets, the brand enters Southeast Asia with confidence — uniting advanced French dermatological innovation with Neoasia’s regional strength.